Previous 10 | Next 10 |
2023-06-29 09:53:00 ET What do CRISPR Therapeutics (NASDAQ: CRSP) , Bluebird Bio (NASDAQ: BLUE) , Editas Medicine (NASDAQ: EDIT) , and Intellia Therapeutics (NASDAQ: NTLA) all have in common? If you said, "They're biotechs developing gene therapies," you're r...
2023-06-27 10:15:00 ET If the consensus price target set by Wall Street analysts is to be believed, CRISPR Therapeutics (NASDAQ: CRSP) stock is going to rise by 49% within the next 12 months. And while there's no telling precisely where its share price will end up next June, the ana...
2023-06-21 09:45:00 ET Over the last couple of weeks, Cathie Wood's ARK Innovation ETF has been busy buying shares of gene-editing biotech Intellia Therapeutics (NASDAQ: NTLA) . She's also been selling some shares of CRISPR Therapeutics (NASDAQ: CRSP) , one of Intellia's...
2023-06-21 07:15:00 ET Despite its shares being down almost 10% over the past five years, there's reason to believe that CRISPR Therapeutics (NASDAQ: CRSP) is finally about to soar. With its first medicines approaching commercialization, and plenty of promising programs in its pipel...
2023-06-20 13:53:44 ET Summary The Food and Drug Administration bestowed Priority Review for their gene therapy. That keeps CRISPR’s candidate ahead of a rival for potential first-to-market. Blockbuster status seems certain given the harsh quality of life for sickle cel...
2023-06-17 09:15:00 ET Cathie Wood, the CEO of Ark Investment, has made a name for herself by betting on cutting-edge technology with financial technology stocks, or fintechs, and biotechnology growth stocks making up a significant part of her exchange-traded funds (ETFs). While many growth...
2023-06-16 17:33:55 ET Summary Crispr Therapeutics and Vertex have now had their Biologics License Application for Exa-cel accepted by the FDA - a decision date is expected in December for Sickle Cell Disease. This is the conclusion of a long development path - proving that this b...
ZUG, Switzerland and CAMBRIDGE, Mass., June 13, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to partic...
2023-06-13 05:30:00 ET CRISPR Therapeutics (NASDAQ: CRSP) and partner Vertex Pharmaceuticals just took another step closer to launching a potential game-changing product. At the same time, the U.S. Food and Drug Administration (FDA) did something that may enter the record books....
2023-06-09 11:10:36 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Carvana (NYSE: CVNA ) stock is still a hot topic among traders on Friday after the used-car retailer updated its outlook yesterday . Carvana stock underwent a rally yest...
News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics AG Company Name:
CRSP Stock Symbol:
NASDAQ Market:
CRISPR Therapeutics AG Website: